The Role of Peroxisome Proliferator-Activated Receptors in Pulmonary Vascular Disease
2007
The Role of PPARs in Lung Blood Vessel Disease
publication
Evidence: moderate
Author Information
Author(s): Rachel E. Nisbet, Roy L. Sutliff, C. Michael Hart
Primary Institution: Emory University
Hypothesis
PPARγ may provide a novel therapeutic target for the treatment of pulmonary hypertension.
Conclusion
PPARγ activation can reduce pulmonary hypertension and improve vascular function.
Supporting Evidence
- PPARγ is reduced in patients with pulmonary hypertension.
- Activation of PPARγ can reduce vascular smooth muscle cell proliferation.
- PPARγ ligands improve endothelial function and reduce oxidative stress.
Takeaway
This study looks at how a specific protein, PPARγ, can help treat high blood pressure in the lungs by improving blood vessel function.
Methodology
The review summarizes recent studies on PPARγ and its effects on pulmonary vascular disease.
Limitations
The review is based on existing literature and does not present new experimental data.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website